258 related articles for article (PubMed ID: 15201644)
1. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Hoffman RM; Duckworth WC; Wendel CS; Shah JH;
Am J Med Sci; 2004 Jun; 327(6):319-23. PubMed ID: 15201644
[TBL] [Abstract][Full Text] [Related]
2. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
[TBL] [Abstract][Full Text] [Related]
3. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.
Hoffman RM; Shah JH; Wendel CS; Duckworth WC; Adam KD; Bokhari SU; Dalton C; Murata GH;
Diabetes Care; 2002 Oct; 25(10):1744-8. PubMed ID: 12351471
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM;
Diabetes Res Clin Pract; 2004 Jul; 65(1):61-7. PubMed ID: 15163479
[TBL] [Abstract][Full Text] [Related]
5. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
6. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
Kempf K; Tankova T; Martin S
Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
[TBL] [Abstract][Full Text] [Related]
7. Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA
Færch K; Alssema M; Mela DJ; Borg R; Vistisen D
Nutr Diabetes; 2018 Jun; 8(1):38. PubMed ID: 29855488
[TBL] [Abstract][Full Text] [Related]
8. Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Murata GH; Shah JH; Wendel CS; Hoffman RM; Adam KD; Bokhari SU; Solvas PA; Duckworth WC
J Diabetes Complications; 2003; 17(4):186-91. PubMed ID: 12810241
[TBL] [Abstract][Full Text] [Related]
9. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
[TBL] [Abstract][Full Text] [Related]
10. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.
Laffel LM; Hsu WC; McGill JB; Meneghini L; Volkening LK
Diabetes Technol Ther; 2007 Jun; 9(3):254-64. PubMed ID: 17561796
[TBL] [Abstract][Full Text] [Related]
11. Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):451-6. PubMed ID: 15049959
[TBL] [Abstract][Full Text] [Related]
12. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
Su JB; Wang XQ; Chen JF; Wu G; Jin Y
Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
[TBL] [Abstract][Full Text] [Related]
13. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study.
Lu J; Ma X; Zhang L; Mo Y; Lu W; Zhu W; Bao Y; Jia W; Zhou J
Diabetes Res Clin Pract; 2020 Mar; 161():108032. PubMed ID: 32006646
[TBL] [Abstract][Full Text] [Related]
14. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
15. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
[TBL] [Abstract][Full Text] [Related]
16. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
17. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
18. Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level.
Ladyzynski P; Foltynski P; Bak MI; Sabalinska S; Krzymien J; Kawiak J
J Transl Med; 2014 Dec; 12():328. PubMed ID: 25491199
[TBL] [Abstract][Full Text] [Related]
19. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
20. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
